Business · 07/08/2019Updated: 10/17/2026 · 1 min read
FDA Publishes Annual Report on Drug and Biologics Firms' Postmarketing Requirements and Commitments
Summary
The US Food and Drug Administration (FDA) has released its annual report on the performance of drug and biologics firms in meeting postmarketing requirements and commitments, as mandated by the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →